Applications And Use Cases Of AI-Powered Medical Devices

Aug 10, 2026

Leave a message

According to the Ministry of Industry and Information Technology (MIIT), speaking at a press conference regarding the implementation of the "15th Five-Year Plan," the development of artificial intelligence (AI) applications in the medical device sector will focus on several key areas. At the application level, the emphasis is on identifying practical use cases, distilling high-value scenarios across different sectors, and exploring a new cultivation model characterized by "one industry, one roadmap" and "one scenario, one profile." Special initiatives will be launched to cultivate application service providers and introduce industry solutions that are lightweight, low-cost, and easy to deploy. On the supply side, support will be provided for the development of products such as intelligent medical devices. Regarding safety and governance, efforts will focus on monitoring AI safety risks, establishing and effectively utilizing a database for AI product security vulnerabilities, and continuously advancing key technologies such as model algorithm security and value alignment.

 

Core applications are concentrated in fields such as AI-assisted medical imaging diagnosis, disease risk prediction, surgical navigation, and robot-assisted procedures. At the hardware level, AI technology requires deep integration with medical equipment; for instance, embedding algorithms into medical imaging devices like CT scanners and ultrasound machines enables end-to-end automation-spanning intelligent patient positioning and automatic scanning to assisted diagnosis. AI is driving the evolution of medical robots from program-controlled systems to those capable of intelligent control and autonomous decision-making by enhancing their perception, interaction, decision-making, and execution capabilities. For example, in oral surgery, multifunctional surgical robots can improve the precision of dental implant procedures from approximately 2 millimeters to within 0.3 millimeters. In the field of continuous glucose monitoring (CGM), products now feature proprietary AI agents specialized in diabetes management; these integrate CGM with capabilities such as AI interaction, dietary recognition, fluctuation analysis, and trend alerts to facilitate the management and interpretation of health data.

 

In the realm of diagnosing and treating brain disorders, companies have developed end-to-end AI-assisted solutions addressing conditions such as intracranial hemorrhage, intracranial aneurysms, brain tumors, and neurodegenerative diseases; these products cover the entire chain of screening, diagnosis, and treatment.

Send Inquiry
Send Inquiry